Selective serotonin reuptake inhibitor use in first trimester pregnancy and risk of congenital anomalies:A EUROmediCAT case-malformed control study in 12 countriesBreidge Boyle, Helen Dolk, Marian K. Bakker et al.|IRIS|2015Cited by 0